NCT06975033 Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP
| NCT ID | NCT06975033 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | HoLEP |
| Study Type | INTERVENTIONAL |
| Enrollment | 114 participants |
| Start Date | 2025-11-04 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 114 participants in total. It began in 2025-11-04 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This will be a randomized interventional study. Patients scheduled to undergo a HoLEP at UCSF will be randomized into two groups after the procedure: one group will watch a scripted educational HoLEP video and the other group will not receive a video. We will monitor the post-operative care utilization after discharge. Secondary outcomes will include patient satisfaction.
Eligibility Criteria
Inclusion Criteria: 1. Adults aged 18+ 2. Patients scheduled for a HoLEP procedure 3. Patients willing to complete both baseline and follow up surveys 4. Patients able to provide informed consent 5. Patients are English-speaking and understand English Exclusion Criteria: 1. Patients under 18+ 2. Patients unable to consent 3. Patients unable to complete surveys 4. Patients without a prostate. 5. Patients are non-English speakers
Contact & Investigator
David Bayne, MD, MPH
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06975033 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying HoLEP. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06975033 currently recruiting?
Yes, NCT06975033 is actively recruiting participants. Contact the research team at david.bayne@ucsf.edu for enrollment information.
Where is the NCT06975033 trial being conducted?
This trial is being conducted at San Francisco, United States, Rochester, United States, Syracuse, United States.
Who is sponsoring the NCT06975033 clinical trial?
NCT06975033 is sponsored by University of California, San Francisco. The principal investigator is David Bayne, MD, MPH at University of California, San Francisco. The trial plans to enroll 114 participants.